Literature DB >> 16610956

Chronic fatigue syndrome and high allostatic load.

Elizabeth M Maloney1, Brian M Gurbaxani, James F Jones, Lucio de Souza Coelho, Cassio Pennachin, Benjamin N Goertzel.   

Abstract

STUDY POPULATION: We examined the relationship between chronic fatigue syndrome (CFS) and allostatic load in a population-based, case-control study of 43 CFS patients and 60 nonfatigued, healthy controls from Wichita, KS, USA.
METHODS: An allostatic load index was computed for all study participants using available laboratory and clinical data, according to a standard algorithm for allostatic load. Logistic regression analysis was used to compute odds ratios (ORs) as estimates of relative risk in models that included adjustment for matching factors and education; 95% confidence intervals (CIs) were computed to estimate the precision of the ORs.
RESULTS: CFS patients were 1.9-times more likely to have a high allostatic load index than controls (95% CI = 0.75, 4.75) after adjusting for education level, in addition to matching factors. The strength of this association increased in a linear trend across categories of low, medium and high levels of allostatic load (p = 0.06).
CONCLUSION: CFS was associated with a high level of allostatic load. The three allostatic load components that best discriminated cases from controls were waist:hip ratio, aldosterone and urinary cortisol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610956     DOI: 10.2217/14622416.7.3.467

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

1.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 2.  Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Olga A Sukocheva; Rebekah Maksoud; Narasimha M Beeraka; SabbaRao V Madhunapantula; Mikhail Sinelnikov; Vladimir N Nikolenko; Margarita E Neganova; Sergey G Klochkov; Mohammad Amjad Kamal; Donald R Staines; Sonya Marshall-Gradisnik
Journal:  J Adv Res       Date:  2021-11-26       Impact factor: 12.822

3.  Higher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.

Authors:  Begoña Ruiz-Núñez; Rabab Tarasse; Emar F Vogelaar; D A Janneke Dijck-Brouwer; Frits A J Muskiet
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-20       Impact factor: 5.555

4.  Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study.

Authors:  Roumiana S Boneva; Jin-Mann S Lin; Friedrich Wieser; Urs M Nater; Beate Ditzen; Robert N Taylor; Elizabeth R Unger
Journal:  Front Pediatr       Date:  2019-05-21       Impact factor: 3.418

5.  Allostatic Load, Single, and Dual Chronic Conditions: Evidence from the National Health and Nutrition Examination Survey.

Authors:  Peter Memiah; Sibhatu Biadgilign; Jamie Kuhlman; Courtney Cook; Piera Mburia; Carol Kingori; Daniel Sarpong; Gabriel Buluku; Marquis Hawkins
Journal:  Metab Syndr Relat Disord       Date:  2021-12-15       Impact factor: 1.894

6.  Pacing, Conventional Physical Activity and Active Video Games to Increase Physical Activity for Adults with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Katia Elizabeth Ferrar; Ashleigh E Smith; Kade Davison
Journal:  JMIR Res Protoc       Date:  2017-08-01

7.  A Conceptual Model to Assess Stress-Associated Health Effects of Multiple Ecosystem Services Degraded by Disaster Events in the Gulf of Mexico and Elsewhere.

Authors:  Paul A Sandifer; Landon C Knapp; Tracy K Collier; Amanda L Jones; Robert-Paul Juster; Christopher R Kelble; Richard K Kwok; John V Miglarese; Lawrence A Palinkas; Dwayne E Porter; Geoffrey I Scott; Lisa M Smith; William C Sullivan; Ariana E Sutton-Grier
Journal:  Geohealth       Date:  2017-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.